Shenzhen Salubris Pharmaceuticals Co., Ltd.
002294
Peringkat dalam Saham
#3418
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Harga Saham
$4.48
Kapitalisasi Pasar
$4.99B
Perubahan (1 hari)
-5.20%
Perubahan (1 tahun)
-41.89%
Negara
CN
Perdagangan Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Kategori
Healthcare
Riwayat dividen untuk Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Saham Shenzhen Salubris Pharmaceuticals Co., Ltd. (simbol: 002294) telah membayar total 16 dividen.
Total semua dividen (disesuaikan dengan stock split): $7.30
Imbal hasil dividen (TTM): 0.0184
Total semua dividen (disesuaikan dengan stock split): $7.30
Imbal hasil dividen (TTM): 0.0184
Pembayaran dividen untuk Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) dari 2010 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (disesuaikan dengan stock split) | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.55 | 10.00% |
| 2025 | $0.5 | 0.00% |
| 2024 | $0.5 | 0.00% |
| 2023 | $0.5 | 25.00% |
| 2022 | $0.4 | -20.00% |
| 2020 | $0.5 | -37.50% |
| 2019 | $0.8 | 0.00% |
| 2018 | $0.8 | 14.29% |
| 2017 | $0.7 | 16.67% |
| 2016 | $0.6 | 37.14% |
| 2015 | $0.4375 | 16.67% |
| 2014 | $0.375 | 28.56% |
| 2013 | $0.2917 | 86.63% |
| 2012 | $0.1563 | 20.05% |
| 2011 | $0.1302 | 139.78% |
| 2010 | $0.0543 | 0.00% |
Daftar semua pembayaran dividen
| Tahun | Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.55 | 10.00% |
| 2025 | $0.5 | 0.00% |
| 2024 | $0.5 | 0.00% |
| 2023 | $0.5 | 25.00% |
| 2022 | $0.4 | -20.00% |
| 2020 | $0.5 | -37.50% |
| 2019 | $0.8 | 0.00% |
| 2018 | $0.8 | 14.29% |
| 2017 | $0.7 | 16.67% |
| 2016 | $0.6 | -14.29% |
| 2015 | $0.7 | 16.67% |
| 2014 | $0.6 | -14.29% |
| 2013 | $0.7 | 55.56% |
| 2012 | $0.45 | -25.00% |
| 2011 | $0.6 | 20.00% |
| 2010 | $0.5 | 0.00% |
Pembayaran dividen untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 27.00% |
FR
|
|
| 52.00% |
JP
|
|
| 175.00% |
US
|
|
| 7.00% |
CH
|
